.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
EPIC-HR evaluated the oral antiviral nirmatrelvir/ritonavir in symptomatic, unvaccinated, high-risk adults with nonhospitalized COVID-19. Early treatment substantially reduced progression to hospitalization or death compared with placebo. The clinical importance extends beyond the original trial population because it established a model of early outpatient antiviral therapy for people at high risk of severe disease. For internists, timing is crucial: treatment must begin soon after symptom onset and eligibility should be assessed rapidly. Ritonavir causes major drug-drug interactions through CYP3A inhibition, so a careful medication review is mandatory. Renal function also affects dosing. The study highlights a broader principle in infectious diseases: when the therapeutic window is narrow, systems that enable rapid diagnosis, risk stratification and prescribing can be as important as the drug itself. In current practice, treatment decisions must be aligned with the circulating variant landscape and up-to-date national guidance.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
EPIC-HR evaluated the oral antiviral nirmatrelvir/ritonavir in symptomatic, unvaccinated, high-risk adults with nonhospitalized COVID-19. Early treatment substantially reduced progression to hospitalization or death compared with placebo. The clinical importance extends beyond the original trial population because it established a model of early outpatient antiviral therapy for people at high risk of severe disease. For internists, timing is crucial: treatment must begin soon after symptom onset and eligibility should be assessed rapidly. Ritonavir causes major drug-drug interactions through CYP3A inhibition, so a careful medication review is mandatory. Renal function also affects dosing. The study highlights a broader principle in infectious diseases: when the therapeutic window is narrow, systems that enable rapid diagnosis, risk stratification and prescribing can be as important as the drug itself. In current practice, treatment decisions must be aligned with the circulating variant landscape and up-to-date national guidance.
last month
Preclinical findings demonstrate that ginsenoside Ra1 preserves vascular integrity and attenuates multi-organ injury during sepsis by targeting non-muscle myosin heavy chain IIA (NMMHC IIA) and dampening TLR4/NF-κB/NLRP3 inflammatory signaling.
2 days back
An all-printed immunosensing microchip detects urinary sFlt-1 in just 10 minutes with 3.61 pg/mL sensitivity. By leveraging photonic bandgap engineering, this low-cost, cleanroom-free platform provides non-invasive preeclampsia screening, offering substantial benefits for point-of-care obstetric triage.
2 days back
Wearable ultrasound patches are transforming healthcare by shifting medicine from episodic evaluations to continuous monitoring. Discover how flexible acoustic transducers advance cardiovascular tracking, musculoskeletal imaging, neuromodulation, and on-demand closed-loop theranostics.
2 days back
A breakthrough study leverages natural language processing to accurately identify incident medication-related osteonecrosis of the jaw and track antiresorptive drug holidays from clinical narratives in electronic health records, advancing osteoporosis pharmacovigilance and dental safety.
Last week
Recent research defines ferro-aging as a conserved iron-lipid axis driving organ decline across primates. Age-related iron dyshomeostasis stimulates ACSL4-mediated lipid peroxidation, promoting cellular senescence. Notably, vitamin C directly inhibits ACSL4, suppressing phospholipid oxidation and multi-organ decay.
Last week
